Ilyang Pharmaceutical Co Ltd
KRX:007570
Ilyang Pharmaceutical Co Ltd
Gross Profit
Ilyang Pharmaceutical Co Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
Ilyang Pharmaceutical Co Ltd
KRX:007570
|
Gross Profit
₩200.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
16%
|
Yuhan Corp
KRX:000100
|
Gross Profit
₩564.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Gross Profit
₩320.8B
|
CAGR 3-Years
137%
|
CAGR 5-Years
211%
|
CAGR 10-Years
N/A
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Gross Profit
₩848.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Gross Profit
₩98.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Gross Profit
₩115.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
22%
|
CAGR 10-Years
13%
|
See Also
What is Ilyang Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
200.3B
KRW
Based on the financial report for Mar 31, 2024, Ilyang Pharmaceutical Co Ltd's Gross Profit amounts to 200.3B KRW.
What is Ilyang Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
16%
Over the last year, the Gross Profit growth was -3%. The average annual Gross Profit growth rates for Ilyang Pharmaceutical Co Ltd have been 2% over the past three years , 5% over the past five years , and 16% over the past ten years .